“…Self-cells are protected from complement activation by the expression of membrane-bound complement inhibitory molecules and soluble serum inhibitors that prevent self-cell complement-mediated injury. However, because the levels, as well as the cellular localization, of these inhibitors can be influenced by environmental factors such as oxidative stress (12) or cigarette smoke (13,14), self-cell surfaces can become targets of complement activation. For example, in AMD, changes in levels and localization of CFH and CD55 (15), CD46 (16), as well as CD59 (17) have been reported in RPE, BrM, and choroid, and have been associated with increased cellular deposition of complement C3 and membrane attack complex in tissue samples (4,18) of patients.…”